Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PacifiCare Would Compete For Stand-Alone Medicare Drug Benefit, CEO Says

Executive Summary

PacifiCare expects to compete for the opportunity to provide a stand-alone Medicare prescription drug benefit if legislation creating the new program passes Congress

You may also be interested in...



WellPoint/Anthem Merger Enhances Number Four PBM, Creates Big Buyer

WellPoint and Anthem see a "significant opportunity" to squeeze pharmaceutical prices as a result of the proposed merger between the two companies

PBM “Carve Out” Model Will Prevail, AdvancePCS CEO Predicts

The division between pharmacy benefit management companies and insurers will become clearer over the next two decades, AdvancePCS CEO David Halbert predicted during an Oct. 28 conference call

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

UsernamePublicRestriction

Register

PS042754

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel